The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation

The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation

Abstract Background Refinement of parameters defining prostate cancer (PC) prognosis are urgently needed to identify patients with indolent versus aggressive disease. The Canadian Prostate Cancer Biomaker Network (CPCBN) consists of researchers from four Canadian provinces to create a validation coh...

Full description

Bibliographic Details
Main Authors: Véronique Ouellet, Armen Aprikian, Alain Bergeron, Fadi Brimo, Robert G. Bristow, Simone Chevalier, Darrel Drachenberg, Ladan Fazli, Neil E. Fleshner, Martin Gleave, Pierre Karakiewicz, Laurence Klotz, Louis Lacombe, Jean-Baptiste Lattouf, Theodorus van der Kwast, Jeremy A. Squire, Mathieu Latour, Dominique Trudel, Anne-Marie Mes-Masson, Fred Saad
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Urology
Subjects:
Prostate cancer
Tissue microarray
Biomarker validation
Immunohistochemistry
Patient prognosis
Online Access:http://link.springer.com/article/10.1186/s12894-018-0392-x

Internet

http://link.springer.com/article/10.1186/s12894-018-0392-x

Similar Items